Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
TUSC3 is a candidate tumor suppressor gene. Additionally we are shipping TUSC3 Antibodies (49) and TUSC3 Proteins (4) and many more products for this protein.
Showing 1 out of 1 products:
Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma
TUSC3 regulates proliferation and invasion of glioblastoma cells by inhibiting the activity of the Akt (show AKT1 ELISA Kits) signaling pathway.
decreased immunological TUSC3 staining is a factor prognostic of poor survival in pancreatic cancer patients.
The TUSC3 gene is associated with mental retardation in the Qinba mountain area in China; the sixth exon of the TUSC3 gene may contribute to the risk of developing the disease.
Report frequencies of short tandem repeat markers linked to TUSC3 (MRT7) or NSUN2 (MRT5 (show NSUN2 ELISA Kits)) genes used for homozygosity mapping of recessive intellectual disability.
TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo
Loss of TUSC3 alters the molecular response to endoplasmic reticulum stress.
IGFII and N33 methylation status may be related to gastric carcinogenesis.
TUSC3 increases glycosylation efficiency for a subset of human glycoproteins by slowing glycoprotein folding.
Homozygous deletion in TUSC3 causes syndromic intellectual disability.
This gene is a candidate tumor suppressor gene. It is located within a homozygously deleted region of a metastatic prostate cancer. The gene is expressed in most nonlymphoid human tissues including prostate, lung, liver, and colon. Expression was also detected in many epithelial tumor cell lines. Two transcript variants encoding distinct isoforms have been identified for this gene.
tumor suppressor candidate 3
, Putative prostate cancer tumor suppressor
, magnesium uptake/transporter TUSC3
, oligosaccharyltransferase 3 homolog A
, putative prostate cancer tumor suppressor